Aberrant promoter methylation of several known or pu-tative tumor suppressor genes occurs frequently during carcinogenesis, and this epigenetic change has been con-sidered as a potential molecular marker for cancer. We examined the methylation status of nine genes (APC, CDH1, CTNNB1, TIMP3, ESR1, GSTP1, MGMT, THBS1, and TMS1), by quantitative methylation specific PCR. Synchronous preinvasive lesions (atypical ductal hyper-plasia and/or ductal carcinoma in situ) and invasive duc-tal breast carcinoma from 52 patients, together with pure lesions from 24 patients and 12 normal tissues paired to tumor and 20 normal breast distant from tumor were analyzed. Aberrant promoter methylation was detected in both preinvasive and invasive lesions for gen...
Disturbances in the epigenetic landscape by aberrant methylation of CpG islands can lead to inactiva...
A distinctive feature of BRCA1-linked breast cancers is that they typically do not express estrogen ...
Background Ductal carcinoma in situ (DCIS) of the breast is a precursor of invasive ...
Aberrant promoter methylation of several known or putative tumor suppressor genes occurs frequently...
Aberrant promoter methylation of several known or pu-tative tumor suppressor genes occurs frequently...
Glutation S-transferase P1 (GSTP1) gene methylation in promoter CpG islands has been described as a ...
Promoter silencing by ectopic de novo methylation of tumor suppressor genes has been proposed as com...
CpG island hypermethylation is known to be asso-ciated with gene silencing in cancer. This epigeneti...
Introduction Ductal carcinoma in situ (DCIS) is a non-invasive lesion of the breast ...
<p>Human tumors undergo massive changes in DNA methylation. Recent studies showed that site-specific...
Background Ductal carcinoma in situ (DCIS) is a heterogeneous, pre-invasive lesion a...
ABSTRACT: BACKGROUND: Aberrant CpG island promoter DNA hypermethylation is frequently observed in ca...
The genetic and epigenetic alterations that underlie cancer pathogenesis are rapidly being identifie...
The genetic and epigenetic alterations that underlie cancer pathogenesis are rapidly being identifie...
While changes in DNA methylation are known to occur early in breast carcinogenesis and the landscape...
Disturbances in the epigenetic landscape by aberrant methylation of CpG islands can lead to inactiva...
A distinctive feature of BRCA1-linked breast cancers is that they typically do not express estrogen ...
Background Ductal carcinoma in situ (DCIS) of the breast is a precursor of invasive ...
Aberrant promoter methylation of several known or putative tumor suppressor genes occurs frequently...
Aberrant promoter methylation of several known or pu-tative tumor suppressor genes occurs frequently...
Glutation S-transferase P1 (GSTP1) gene methylation in promoter CpG islands has been described as a ...
Promoter silencing by ectopic de novo methylation of tumor suppressor genes has been proposed as com...
CpG island hypermethylation is known to be asso-ciated with gene silencing in cancer. This epigeneti...
Introduction Ductal carcinoma in situ (DCIS) is a non-invasive lesion of the breast ...
<p>Human tumors undergo massive changes in DNA methylation. Recent studies showed that site-specific...
Background Ductal carcinoma in situ (DCIS) is a heterogeneous, pre-invasive lesion a...
ABSTRACT: BACKGROUND: Aberrant CpG island promoter DNA hypermethylation is frequently observed in ca...
The genetic and epigenetic alterations that underlie cancer pathogenesis are rapidly being identifie...
The genetic and epigenetic alterations that underlie cancer pathogenesis are rapidly being identifie...
While changes in DNA methylation are known to occur early in breast carcinogenesis and the landscape...
Disturbances in the epigenetic landscape by aberrant methylation of CpG islands can lead to inactiva...
A distinctive feature of BRCA1-linked breast cancers is that they typically do not express estrogen ...
Background Ductal carcinoma in situ (DCIS) of the breast is a precursor of invasive ...